PhD Candidate: Translational CAR‑T for Pediatric Tumors

Unist; Madrid; On-site; EUR 26,000 - 30,000; Part time

Job summary

Autonomous University of Madrid seeks a PhD candidate to join a translational project focused on CAR‑T therapies for pediatric CNS tumors, including rhabdoid tumors. You will work in a multidisciplinary team spanning molecular biology, immunology, and clinical hemato‑oncology, contributing to data generation, analysis, and interpretation of findings in line with current literature.

The role combines extensive in‑vitro culture with patient-derived samples and in‑vivo murine validation to assess

Qualifications

• University degree in Biology, Biomedicine, Biotechnology, Pharmacy, Medicine, or related life sciences discipline.
• Solid theoretical background in cellular immunology and/or cancer biology; interest in cell/gene therapy approaches.
• Practical experience in cell culture and basic molecular biology methods (e.g., flow cytometry, cytotoxicity assays).
• Willingness to work with laboratory animals (murine models).
• Motivation to participate in outreach and public engagement activities.

Responsibilities

• Design, development, and preclinical validation of CAR‑T cell therapies targeting pediatric CNS tumors (rhaboid/AT/RT).
• Lead data generation, analysis, and interpretation in context of current literature.
• Perform in‑vitro cell culture experiments with patient-derived samples and in‑vivo validation in murine models.

Skills

Biology/Biomedicine background

Immunotherapy interest

Cell culture experience

Flow cytometry

Molecular biology techniques

English proficiency

Team collaboration

Outreach and public engagement

Education

Biology/Biomedicine/Pharmacy degree

Tools

Flow cytometry

Lentiviral vector production

Lentiviral transduction

Job description

Autonomous University of Madrid seeks a PhD candidate to join a translational project focused on CAR‑T therapies for pediatric CNS tumors, including rhabdoid tumors. You will work in a multidisciplinary team spanning molecular biology, immunology, and clinical hemato‑oncology, contributing to data generation, analysis, and interpretation of findings in line with current literature.

The role combines extensive in‑vitro culture with patient-derived samples and in‑vivo murine validation to assess